Anne Jensen Has Spent a Decade Turning Cell Motion Into Executive Momentum

She began by engineering ways to read rare cells in blood. At Cytovale, Anne Jensen has carried that same eye for signals from the research bench into the decisions that shape a growing diagnostics company.